Alastair Gray
Names
| first: |
Alastair |
| middle: |
McIntosh |
| last: |
Gray |
Identifer
Contact
| homepage: |
http://www.herc.ox.ac.uk |
|
| phone: |
01865 289279 |
| postal address: |
Health Economics Research Centre University of Oxford Old Road Campus Headington Oxford OX3 7LF UK |
Affiliations
-
Oxford University
/ Health Economics Research Centre (HERC)
Research profile
author of:
- Obesity as Market Failure: Could a ‘Deliberative Economy’ Overcome the Problems of Paternalism? (RePEc:bla:kyklos:v:62:y:2009:i:2:p:182-190)
by Paul Anand & Alastair Gray - The Impact of Risk Management Standards on Patient Safety: The Determinants of MRSA Infections in Acute NHS Hospitals, 2001–08 (RePEc:bla:obuest:v:75:y:2013:i:3:p:340-361)
by Paul Fenn & Alastair Gray & Neil Rickman & Oliver Rivero-Arias & Dev Vencappa - Health Economics: A Review Article (RePEc:bla:scotjp:v:27:y:1980:i:3:p:297-304)
by Gray, Alastair - The Production of Dental Care in the British National Health Service (RePEc:bla:scotjp:v:29:y:1982:i:1:p:59-74)
by Gray, Alastair McI - Staff turnover in the NHS: a preliminary economic analysis (RePEc:chy:respap:46chedp)
by Alastair Gray & Charles Normand & Elizabeth Currie - Care in the community: a study of services and costs in six districts (RePEc:chy:respap:6cheop)
by Alastair Gray & Angela Whelan & Charles Normand - The Economics of Clinical Negligence Reform in England (RePEc:ecj:econjl:v:114:y:2004:i:496:p:f272-f292)
by Paul Fenn & Alastair Gray & Neil Rickman - Forecasting the impact of demographic change: the case of the British National Health Service (RePEc:eee:hepoli:v:20:y:1992:i:3:p:269-275)
by Gray, Alastair M. & Bosanquet, Nick - Labour turnover in the British National Health Service: a local labour market analysis (RePEc:eee:hepoli:v:36:y:1996:i:3:p:273-289)
by Gray, Alastair M. & Phillips, V. L. - The costs of nursing turnover: evidence from the British National Health Service (RePEc:eee:hepoli:v:38:y:1996:i:2:p:117-128)
by Gray, Alastair M. & Phillips, V. L. & Normand, Charles - From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap (RePEc:eee:hepoli:v:89:y:2009:i:2:p:193-200)
by Legood, Rosa & Wolstenholme, Jane & Gray, Alastair - A longitudinal study of the effects of age and time to death on hospital costs (RePEc:eee:jhecon:v:23:y:2004:i:2:p:217-235)
by Seshamani, Meena & Gray, Alastair M. - Liability, insurance and medical practice (RePEc:eee:jhecon:v:26:y:2007:i:5:p:1057-1070)
by Fenn, Paul & Gray, Alastair & Rickman, Neil - Wellbeing over 50 (RePEc:eee:joecag:v:6:y:2015:i:c:p:68-78)
by Anand, Paul & Gray, Alastair & Liberini, Federica & Roope, Laurence & Smith, Ron & Thomas, Ranjeeta - Programme budgeting in the health sector (RePEc:eee:jomega:v:7:y:1979:i:5:p:451-458)
by Gray, Alastair & Steele, Robert - Changing experience of adverse medical events in the National Health Service: Comparison of two population surveys in 2001 and 2013 (RePEc:eee:socmed:v:195:y:2017:i:c:p:83-89)
by Gray, Alastair M. & Fenn, Paul & Rickman, Neil & Vencappa, Dev - Risk attitudes of people with ‘manageable’ chronic disease: An analysis under prospect theory (RePEc:eee:socmed:v:214:y:2018:i:c:p:144-153)
by Rouyard, Thomas & Attema, Arthur & Baskerville, Richard & Leal, José & Gray, Alastair - Operationalising the capability approach for outcome measurement in mental health research (RePEc:eee:socmed:v:98:y:2013:i:c:p:187-196)
by Simon, Judit & Anand, Paul & Gray, Alastair & Rugkåsa, Jorun & Yeeles, Ksenija & Burns, Tom - Cost of poor adherence to anti-hypertensive therapy in five European countries (RePEc:hal:journl:hal-01616348)
by F.S. Mennini & A. Marcellusi & J.M. Graf von Der Schulenburg & A. Gray & Pierre Lévy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. E. Schmieder - The reform of Legal Aid in England and Wales (RePEc:ifs:fistud:v:20:y:1999:i:3:p:261-286)
by Neil Rickman & Paul Fenn & Alastair Gray - Reducing Harm to Patients in the National Health Service. Will the Government’s Compensation Proposals Help? (RePEc:ohe:briefg:000484)
by Paul Fenn;Alastair Gray;Neil Rickman;Rodrigo Salinas;Adrian Towse - Unknown item RePEc:ohe:conrep:000265 (paper)
- Wellbeing Over 50: A Capabilities Approach (RePEc:opn:wpaper:77)
by Paul Anand & Ranjeeta Thomas & Alastair Gray - Professional Autonomy and the Cost of Legal Aid (RePEc:oup:oxecpp:v:51:y:1999:i:3:p:545-58)
by Gray, Alastair & Rickman, Neil & Fenn, Paul - Standard fees for legal aid: an empirical analysis of incentives and contracts (RePEc:oup:oxecpp:v:59:y:2007:i:4:p:662-681)
by Paul Fenn & Alastair Gray & Neil Rickman - The Reform of Legal Aid (RePEc:oup:oxford:v:10:y:1994:i:1:p:51-67)
by Gray, Alastair M - Economic evaluation of healthcare interventions: old and new directions (RePEc:oup:oxford:v:32:y:2016:i:1:p:102-121.)
by Alastair M. Gray & Thomas Wilkinson - Applied Methods of Cost-effectiveness Analysis in Healthcare (RePEc:oxp:obooks:9780199227280)
by Gray, Alastair M. & Clarke, Philip M. & Wolstenholme, Jane L. & Wordsworth, Sarah - Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis (RePEc:plo:pntd00:0008983)
by Jonathan Kitonsa & Julius Kiwanuka & Zacchaeus Anywaine & Sheila Kansiime & Kenneth Katumba & Namirembe Aeron & Justin Beardsley & Freddie Kibengo & Alastair Gray & Pontiano Kaleebu & Jeremy Day - Cost-Effectiveness of Pre-Referral Antimalarial, Antibacterial, and Combined Rectal Formulations for Severe Febrile Illness (RePEc:plo:pone00:0014446)
by James Buchanan & Borislava Mihaylova & Alastair Gray & Nicholas White - Resource Use and Costs Associated with Coeliac Disease before and after Diagnosis in 3,646 Cases: Results of a UK Primary Care Database Analysis (RePEc:plo:pone00:0041308)
by Mara Violato & Alastair Gray & Irini Papanicolas & Melissa Ouellet - A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research Centres (RePEc:plo:pone00:0214361)
by Joel B E Smith & Keith Channon & Vasiliki Kiparoglou & John F Forbes & Alastair M Gray - Correction: A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research Centres (RePEc:plo:pone00:0216315)
by Joel B E Smith & Keith M Channon & Vasiliki Kiparoglou & John F Forbes & Alastair M Gray - Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe (RePEc:rtv:ceisrp:299)
by Francesco Saverio Mennini & Andrea Marcellusi & J.Matthias Graf von der Schulenburg & Alastair Gray & Pierre L. Levy & Paolo Sciattella & Marco Soro & Gianandrea Staffiero & Jan Zeidler & Aldo Maggion - Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis (RePEc:sae:medema:v:18:y:1998:i:2_suppl:p:s81-s92)
by Andrew H. Briggs & Alastair M. Gray - Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62) (RePEc:sae:medema:v:22:y:2002:i:4:p:340-349)
by Philip Clarke & Alastair Gray & Rury Holman - Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping (RePEc:sae:medema:v:26:y:2006:i:1:p:18-29)
by Alastair M. Gray & Oliver Rivero-Arias & Philip M. Clarke - Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome (RePEc:sae:medema:v:30:y:2010:i:3:p:341-354)
by Oliver Rivero-Arias & Melissa Ouellet & Alastair Gray & Jane Wolstenholme & Peter M. Rothwell & Ramon Luengo-Fernandez - Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities (RePEc:sae:medema:v:30:y:2010:i:3:p:409-414)
by Hermione C. Price & Philip M. Clarke & Alastair M. Gray & Rury R. Holman - Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement (RePEc:sae:medema:v:35:y:2015:i:6:p:np1-np8)
by Stavros Petrou & Oliver Rivero-Arias & Helen Dakin & Louise Longworth & Mark Oppe & Robert Froud & Alastair Gray - Mapping from the Parkinson’s Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L (RePEc:sae:medema:v:35:y:2015:i:7:p:902-911)
by Seamus Kent & Alastair Gray & Iryna Schlackow & Crispin Jenkinson & Emma McIntosh - Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions (RePEc:sae:medema:v:38:y:2018:i:4:p:476-486)
by Helen Dakin & Alastair Gray - Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data (RePEc:sae:medema:v:40:y:2020:i:4:p:460-473)
by Helen A. Dakin & José Leal & Andrew Briggs & Philip Clarke & Rury R. Holman & Alastair Gray - Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Chal (RePEc:sae:medema:v:42:y:2022:i:5:p:599-611)
by Michelle Tew & Michael Willis & Christian Asseburg & Hayley Bennett & Alan Brennan & Talitha Feenstra & James Gahn & Alastair Gray & Laura Heathcote & William H. Herman & Deanna Isaman & Shihchen Kuo - Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement (RePEc:spr:aphecp:v:13:y:2015:i:5:p:437-443)
by Stavros Petrou & Oliver Rivero-Arias & Helen Dakin & Louise Longworth & Mark Oppe & Robert Froud & Alastair Gray - Cost of poor adherence to anti-hypertensive therapy in five European countries (RePEc:spr:eujhec:v:16:y:2015:i:1:p:65-72)
by F. Mennini & A. Marcellusi & J. Schulenburg & A. Gray & P. Levy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. Schmieder - Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country (RePEc:spr:eujhec:v:16:y:2015:i:8:p:909-911)
by F. Mennini & Andrea Marcellusi & J. Schulenburg & A. Gray & P. Levy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. Schmieder - The Use and Cost of HIV Service Provision in England in 1996 (RePEc:spr:pharme:v:14:y:1998:i:6:p:639-652)
by Eduard Beck & Keith Tolley & Amanda Power & Sundhiya Mandalia & Philippa Rutter & Junichi Izumi & Jeni Beecham & Alistair Gray & David Barlow & Philippa Easterbrook & Martin Fisher & John Innes & Geor - A Systematic Review and Critical Assessment of Health State Utilities (RePEc:spr:pharme:v:30:y:2012:i:12:d:10.2165_11599420-000000000-00000)
by Scott Doyle & Andrew Lloyd & Lee Moore & Joshua Ray & Alastair Gray - A Systematic Review and Critical Assessment of Health State Utilities (RePEc:spr:pharme:v:30:y:2012:i:12:p:1133-1143)
by Scott Doyle & Andrew Lloyd & Lee Moore & Joshua Ray & Alastair Gray - Improving Clinical Reality in Chronic Obstructive Pulmonary Disease Economic Modelling (RePEc:spr:pharme:v:31:y:2013:i:2:p:151-161)
by Yumi Asukai & Michael Baldwin & Tiago Fonseca & Alastair Gray & Laura Mungapen & David Price - Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement (RePEc:spr:pharme:v:33:y:2015:i:10:p:985-991)
by Stavros Petrou & Oliver Rivero-Arias & Helen Dakin & Louise Longworth & Mark Oppe & Robert Froud & Alastair Gray - The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration (RePEc:spr:pharme:v:33:y:2015:i:10:p:993-1011)
by Stavros Petrou & Oliver Rivero-Arias & Helen Dakin & Louise Longworth & Mark Oppe & Robert Froud & Alastair Gray - Current UK Practices on Health Economics Analysis Plans (HEAPs): Are We Using Heaps of Them? (RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0598-x)
by Melina Dritsaki & Alastair Gray & Stavros Petrou & Susan Dutton & Sarah E. Lamb & Joanna C. Thorn - The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood (RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00825-1)
by Seamus Kent & Frauke Becker & Talitha Feenstra & An Tran-Duy & Iryna Schlackow & Michelle Tew & Ping Zhang & Wen Ye & Shi Lizheng & William Herman & Phil McEwan & Wendelin Schramm & Alastair Gray & Jo - Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK (RePEc:spr:pharme:v:41:y:2023:i:5:d:10.1007_s40273-022-01219-6)
by Junwen Zhou & Runguo Wu & Claire Williams & Jonathan Emberson & Christina Reith & Anthony Keech & John Robson & Kenneth Wilkinson & Jane Armitage & Alastair Gray & John Simes & Colin Baigent & Borisla - Liability, insurance and defensive medicine: new evidence (RePEc:sur:surrec:0304)
by Paul Fenn & Alastair Gray & Neil Rickman - Ageing and health‐care expenditure: the red herring argument revisited (RePEc:wly:hlthec:v:13:y:2004:i:4:p:303-314)
by Meena Seshamani & Alastair Gray - The valuation of prenatal life in economic evaluations of perinatal interventions (RePEc:wly:hlthec:v:18:y:2009:i:4:p:487-494)
by Judit Simon & Stavros Petrou & Alastair Gray - Professor Gavin Mooney 1943–2012 (RePEc:wly:hlthec:v:22:y:2013:i:4:p:371-372)
by Alastair Gray & Alistair McGuire - The Effect Of Diabetes Complications On Health‐Related Quality Of Life: The Importance Of Longitudinal Data To Address Patient Heterogeneity (RePEc:wly:hlthec:v:23:y:2014:i:4:p:487-500)
by Maria Alva & Alastair Gray & Borislava Mihaylova & Philip Clarke - An exercise on the feasibility of carrying out secondary economic analyses (RePEc:wly:hlthec:v:5:y:1996:i:2:p:155-165)
by Tom Jefferson & Miranda Mugford & Alastair Gray & Vittorio Demicheli - Centre‐specific or average unit costs in multi‐centre studies? Some theory and simulation (RePEc:wly:hlthec:v:9:y:2000:i:3:p:191-198)
by M. Raikou & A. Briggs & A. Gray & A. McGuire